In a statement on the same day, Apple pledged to purchase US-made rare earth magnets developed at MP Materials Corp.’s (NYSE:MP) flagship Independence facility in Fort Worth, Texas, and that it

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, top-rated podcasts, and non-profit The Motley Fool Foundation.

Ultragenyx received a Complete Response Letter from the FDA for UX111 AAV gene therapy to treat Sanfilippo Syndrome Type A (MPS IIIA). Ultragenyx Pharmaceutical shares dipped 8% to $27.15 in the pre-market trading session. Here are some other stocks moving lower in pre-market trading.

Chief Executive Elon Musk said Saturday he had [created a new political party](

Three companies that I think can surpass Apple by 2030 are Amazon ( AMZN -0.13%), Alphabet ( GOOG 0.49%) ( GOOGL 0.49%), and Meta Platforms ( META -0.69%). The paths that each stock needs to take to get there are different, but I think that it's doable within the next five years.

Apple’s online sales growth has been staggering, more than doubling between 2019 and 2021, thanks to COVID, before seeing it decline in 2023 as the pandemic ended.

If you’re invested in the so-called Magnificent Seven stocks, here’s what you can do to boost your portfolio’s performance: Kick out Tesla TSLA and Apple AAPL. Keep the other five: Nvidia NVDA; Microsoft MSFT;

Apple has created a powerful and sticky ecosystem, but sizable growth is difficult to come by these days. Thanks to impressive profitability, Apple will continue to return massive amounts of cash to shareholders.

If you currently hold Tesla (NASDAQ: TSLA) and Apple (NASDAQ: APPL)—two popular Magnificent Seven stocks—you might want to consider rotating out of them and into Broadcom (NASDAQ: AVGO) and Oracle (NYSE: ORCL) instead.